These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20180772)

  • 1. The fibroblast growth factor 23: a new player in the field of cardiovascular, bone and renal disease.
    Cozzolino M; Mazzaferro S
    Curr Vasc Pharmacol; 2010 May; 8(3):404-11. PubMed ID: 20180772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What would we like to know, and what do we not know about fibroblast growth factor 23?
    Cozzolino M; Galassi A; Apetrii M; Covic A
    J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23: a key player in mineral and bone disorder in CKD.
    Komaba H; Fukagawa M
    Nefrologia; 2009; 29(5):392-6. PubMed ID: 19820750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
    Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ
    PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
    Damasiewicz MJ; Toussaint ND; Polkinghorne KR
    Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF23: its role in renal bone disease.
    Fukagawa M; Kazama JJ
    Pediatr Nephrol; 2006 Dec; 21(12):1802-6. PubMed ID: 16932898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23 and mineral metabolism, implications in CKD-MBD.
    Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
    Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde.
    Cianciolo G; Cozzolino M
    Clin Kidney J; 2016 Oct; 9(5):665-8. PubMed ID: 27679712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kidney and bone update : the 5-year history and future of CKD-MBD. CKD-MBD and phosphotropic hormones].
    Fukumoto S
    Clin Calcium; 2012 Jul; 22(7):987-91. PubMed ID: 22750930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate Toxicity in CKD: The Killer among Us.
    Ritter CS; Slatopolsky E
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):1088-1100. PubMed ID: 26912542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho].
    Mazzaferro S; Pasquali M; Tartaglione L; Rotondi S; Pirrò G
    G Ital Nefrol; 2009; 26 Suppl 49():S11-7. PubMed ID: 19941273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate and FGF-23.
    Jüppner H
    Kidney Int Suppl; 2011 Apr; 79(121):S24-7. PubMed ID: 21346724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspect of recent progress in phosphate metabolism. Pathophysiology of secondary hyperparathyroidism in chronic kidney disease].
    Goto S; Fukagawa M
    Clin Calcium; 2009 Jun; 19(6):809-14. PubMed ID: 19483275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic kidney disease (CKD) and bone. Regulation of calcium and phosphate metabolism by FGF23/Klotho].
    Fukumoto S
    Clin Calcium; 2009 Apr; 19(4):523-8. PubMed ID: 19329831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.